TALIS BIOMEDICAL CORP (TLIS)

US87424L2079 - Common Stock

9.15  +0.05 (+0.55%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.20M4.81M8.19M10.94M3.98M
Cost Of Goods
2.37M8.39MN/AN/AN/A
Gross Profit
-176.00K-3.58MN/AN/AN/A
Operating Expenses
77.50M111.56M200.01M102.12M30.68M
Research and Development
47.90M70.83M157.59M89.02M23.81M
Selling, General, and Administrative Expenses
29.61M40.73M42.42M13.10M6.86M
Operating Income
-77.67M-115.14M-191.82M-91.18M-26.70M
Interest Income/Expense
N/AN/AN/A50.00K40.00K
Other Income/Expense
5.00M2.13M-220.00K0.00-820.00K
Income Before Taxes
-75.47M-113.01M-192.04M-91.13M-27.47M
Net Income
-75.47M-113.01M-192.04M-91.13M26.38M
EBITDA
-73.55M-106.31M-190.24M-90.42M-25.97M
 
Per Share Data
EPS Diluted Total Ops
-41.89-63.48-127.17-58.0416.80
Non GAAP EPS
N/A-63.60-27.51N/AN/A
 
Statistics
Gross Profit Margin
-8.00%-74.43%N/AN/AN/A
Profit Margin
-3430.55%-2349.48%-2344.81%-833.00%662.81%
Operating Profit Margin
-3530.50%-2393.76%-2342.12%-833.46%-670.85%

All data in USD

Charts